Sorry, you need to enable JavaScript to visit this website.

A Study on How Lotiglipron Is Processed in Adults with Diabetes and Kidney Dysfunction

A Phase 1, Open-Label, Single-Dose, Parallel-Group Study to Evaluate the Pharmacokinetics of PF-07081532 in Adult Participants with Type 2 Diabetes Mellitus with Varying Degrees of Renal Impairment Relative to Participants without Renal Impairment

Category & Conditions: Diabetes and Metabolic Disorders
Medicine: PF-07081532
ClinicalTrials.gov Identifier (NCT): NCT05510245
Protocol ID: C3991007
PrintDownload
Open Plain Language Summary Result: Click here